Supernus制药 SUPN 深 沪
交易中 03-31 10:18:34 美东时间
51.22
+1.870
+3.79%
华盛通- 最 高51.37
- 今 开49.81
- 成交量 3.39万股
- 最 低 49.645
- 昨 收 49.35
- 总市值 29.49亿
- 52周最高 59.68
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 29.16
- 委 比 0.00%
- 总股本 5758.17万
- 历史最高 61.25
- 量 比 0.77
- 振 幅 3.50%
- 历史最低 4.30
- 每 手 1
- 风险率 8.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Supernus Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results.
Supernus Pharmaceuticals shares are trading higher after the company reported b...
02-25 22:25
财报速睇 | Supernus制药 2025财年Q4营收2.12亿美元，同比增长21.8%；归母净利润亏损0.04亿美元，由盈转亏
华盛资讯2月25日讯，Supernus制药公布2025财年Q4业绩，公司Q4营收2.12亿美元，同比增长21.8%，归母净利润亏损0.04亿美元，由盈转亏。
02-25 06:10
Supernus Pharmaceuticals Sees FY2026 Sales $840.000M-$870.000M vs $860.987M Est
Supernus Pharmaceuticals (NASDAQ:SUPN) sees FY2026 sales of $840.000 million-$870.000 million vs $860.987 million analyst estimate.
02-25 05:13
Supernus Pharmaceuticals Q4 EPS $(0.07) Beats $(0.16) Estimate, Sales $211.572M Beat $195.004M Estimate
Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.16) by 56.25 percent. This is a 125.93 percent decrease over earnings of $0.27 per
02-25 05:09
Earnings Scheduled For February 24, 2026
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
美股大行评级 | 绩后评级出炉！联邦快递获多家大行上调目标价；耐克遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Pyxis Oncology"买入"评级，目标价从5美元升至7美元；Stifel：维持Oculis Holding"买入"评级，目标价从35美元升至40美元
2025-12-22 15:05
Stifel Maintains Hold on Supernus Pharmaceuticals, Raises Price Target to $55
Stifel analyst Annabel Samimy maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a Hold and raises the price target from $50 to $55.
2025-12-19 22:53
美股盘后 | Supernus制药跌11.14%
Supernus制药预计2025年11月发布财报，预期每股收益0.62美元，营收1.8096亿美元。公司今年前两季度业绩均未达预期，第二季度收入同比下降1.71%，主要开发中枢神经系统疾病药物，包括癫痫和帕金森病等治疗药物。
2025-11-05 05:43
Supernus Pharmaceuticals shares are trading lower. The company reported Q3 financial results.
Supernus Pharmaceuticals shares are trading lower. The company reported Q3 fina...
2025-11-05 05:40
